Kantoff PW - Search Results

1

A Phase II Trial of Abiraterone Combined with Dutasteride for Men with Metastatic Castration-Resistant Prostate Cancer.

McKay RR, Werner L, Mostaghel EA, Lis R, Voznesensky O, Zhang Z, Marck BT, Matsumoto AM, Domachevsky L, Zukotynski KA, Bhasin M, Bubley GJ, Montgomery B, Kantoff PW, Balk SP, Taplin ME. McKay RR, et al. Among authors: kantoff pw. Clin Cancer Res. 2017 Feb 15;23(4):935-945. doi: 10.1158/1078-0432.CCR-16-0987. Epub 2016 Sep 28. Clin Cancer Res. 2017. PMID: 27683182 Free PMC article. Clinical Trial.

2

Detection of circulating tumor cells in men with localized prostate cancer.

Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, et al. Seiden MV, et al. Among authors: kantoff pw. J Clin Oncol. 1994 Dec;12(12):2634-9. doi: 10.1200/JCO.1994.12.12.2634. J Clin Oncol. 1994. PMID: 7527455

3

14-Day continuous infusion of mitoxantrone in hormone-refractory metastatic adenocarcinoma of the prostate.

Kantoff PW, Block C, Letvak L, George M. Kantoff PW, et al. Am J Clin Oncol. 1993 Dec;16(6):489-91. doi: 10.1097/00000421-199312000-00005. Am J Clin Oncol. 1993. PMID: 8256762 Clinical Trial.

4

The prostate specific antigen. Its use as a tumor marker for prostate cancer.

Kantoff PW, Talcott JA. Kantoff PW, et al. Hematol Oncol Clin North Am. 1994 Jun;8(3):555-72. Hematol Oncol Clin North Am. 1994. PMID: 8707772 Review.

5

Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma.

Ghossein RA, Rosai J, Scher HI, Seiden M, Zhang ZF, Sun M, Chang G, Berlane K, Krithivas K, Kantoff PW. Ghossein RA, et al. Among authors: kantoff pw. Urology. 1997 Jul;50(1):100-5. doi: 10.1016/S0090-4295(97)00127-1. Urology. 1997. PMID: 9218026

6

The androgen receptor gene GGN microsatellite and prostate cancer risk.

Platz EA, Giovannucci E, Dahl DM, Krithivas K, Hennekens CH, Brown M, Stampfer MJ, Kantoff PW. Platz EA, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):379-84. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9610786 Clinical Trial.

7

A prognostic score for hormone-refractory prostate cancer: analysis of two cancer and leukemia group B studies.

Vollmer RT, Kantoff PW, Dawson NA, Vogelzang NJ. Vollmer RT, et al. Among authors: kantoff pw. Clin Cancer Res. 1999 Apr;5(4):831-7. Clin Cancer Res. 1999. PMID: 10213219 Clinical Trial.

8

A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma.

Oh WK, Manola J, Richie JP, Loughlin KR, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. Cancer. 1999 Oct 1;86(7):1329-34. doi: 10.1002/(sici)1097-0142(19991001)86:7<1329::aid-cncr31>3.0.co;2-r. Cancer. 1999. PMID: 10506721 Clinical Trial.

9

Treatment of locally advanced prostate cancer: is chemotherapy the next step?

Oh WK, Kantoff PW. Oh WK, et al. Among authors: kantoff pw. J Clin Oncol. 1999 Nov;17(11):3664-75. doi: 10.1200/JCO.1999.17.11.3664. J Clin Oncol. 1999. PMID: 10550165 Review.

10

Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study.

Kantoff PW, Halabi S, Conaway M, Picus J, Kirshner J, Hars V, Trump D, Winer EP, Vogelzang NJ. Kantoff PW, et al. J Clin Oncol. 1999 Aug;17(8):2506-13. doi: 10.1200/JCO.1999.17.8.2506. J Clin Oncol. 1999. PMID: 10561316 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

478 results

Search Page